Milan, Italy

Adolfo Prandi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Irbm S.p.a., Istituto Nazionale Di Genetica Molecolare - Ingm, Ospedale San Raffaele S.r.l.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adolfo Prandi. Retrieved from https://idiyas.com/inventor/adolfo-prandi-o8skhxyx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adolfo Prandi - Innovator in Hepatitis B Research

Introduction: Adolfo Prandi is an inventor based in Milano, Italy. He has made significant contributions to the field of medical research, particularly in the area of hepatitis B virus (HBV) treatment. Although he currently holds no granted patents, his work is noteworthy for its potential impact on public health.

Latest Patent Applications: Adolfo Prandi has filed several patent applications related to his research. One of his latest applications is for "Inhibitors of Hepatitis B Virus." This invention relates to compounds that inhibit HBV, which are useful alone or in combination with other agents for treating, ameliorating, preventing, or curing HBV infection and related conditions. The invention also includes pharmaceutical compositions containing these compounds. Another application is for "Oxalamido-Substituted Tricyclic Inhibitors of Hepatitis B Virus," which shares similar objectives and applications as the previous invention.

Conclusion: Adolfo Prandi's work in hepatitis B research highlights his commitment to advancing medical science, even in the absence of granted patents. His innovative approaches may pave the way for future treatments and contribute to the fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…